SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-013976
Filing Date
2022-03-22
Accepted
2022-03-22 06:05:01
Documents
14
Period of Report
2022-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea157216-8k_inmedpharma.htm   iXBRL 8-K 42678
2 FORM OF AMENDMENT OF PURCHASE AGREEMENT AND COMMON STOCK PURCHASE WARRANT, DATED ea157216ex10-1_inmedpharma.htm EX-10.1 38825
  Complete submission text file 0001213900-22-013976.txt   292356

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20220321.xsd EX-101.SCH 3039
4 XBRL DEFINITION FILE inm-20220321_def.xml EX-101.DEF 26451
5 XBRL LABEL FILE inm-20220321_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE inm-20220321_pre.xml EX-101.PRE 22600
8 EXTRACTED XBRL INSTANCE DOCUMENT ea157216-8k_inmedpharma_htm.xml XML 3650
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 22757135
SIC: 2834 Pharmaceutical Preparations